Cargando…
CRISPR/Cas9 genome-edited universal CAR T cells in patients with relapsed/refractory lymphoma
| Autores principales: | , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
American Society of Hematology
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9043938/ https://www.ncbi.nlm.nih.gov/pubmed/35008103 http://dx.doi.org/10.1182/bloodadvances.2021006232 |
| _version_ | 1784694995487293440 |
|---|---|
| author | Guo, Yelei Tong, Chuan Su, Liping Zhang, Wenying Jia, Hejin Liu, Yang Yang, Qingming Wu, Zhiqiang Wang, Yao Han, Weidong |
| author_facet | Guo, Yelei Tong, Chuan Su, Liping Zhang, Wenying Jia, Hejin Liu, Yang Yang, Qingming Wu, Zhiqiang Wang, Yao Han, Weidong |
| author_sort | Guo, Yelei |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9043938 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | American Society of Hematology |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-90439382022-04-28 CRISPR/Cas9 genome-edited universal CAR T cells in patients with relapsed/refractory lymphoma Guo, Yelei Tong, Chuan Su, Liping Zhang, Wenying Jia, Hejin Liu, Yang Yang, Qingming Wu, Zhiqiang Wang, Yao Han, Weidong Blood Adv Research Letter American Society of Hematology 2022-04-25 /pmc/articles/PMC9043938/ /pubmed/35008103 http://dx.doi.org/10.1182/bloodadvances.2021006232 Text en © 2022 by The American Society of Hematology. Licensed under Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0), permitting only noncommercial, nonderivative use with attribution. All other rights reserved. |
| spellingShingle | Research Letter Guo, Yelei Tong, Chuan Su, Liping Zhang, Wenying Jia, Hejin Liu, Yang Yang, Qingming Wu, Zhiqiang Wang, Yao Han, Weidong CRISPR/Cas9 genome-edited universal CAR T cells in patients with relapsed/refractory lymphoma |
| title | CRISPR/Cas9 genome-edited universal CAR T cells in patients with relapsed/refractory lymphoma |
| title_full | CRISPR/Cas9 genome-edited universal CAR T cells in patients with relapsed/refractory lymphoma |
| title_fullStr | CRISPR/Cas9 genome-edited universal CAR T cells in patients with relapsed/refractory lymphoma |
| title_full_unstemmed | CRISPR/Cas9 genome-edited universal CAR T cells in patients with relapsed/refractory lymphoma |
| title_short | CRISPR/Cas9 genome-edited universal CAR T cells in patients with relapsed/refractory lymphoma |
| title_sort | crispr/cas9 genome-edited universal car t cells in patients with relapsed/refractory lymphoma |
| topic | Research Letter |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9043938/ https://www.ncbi.nlm.nih.gov/pubmed/35008103 http://dx.doi.org/10.1182/bloodadvances.2021006232 |
| work_keys_str_mv | AT guoyelei crisprcas9genomeediteduniversalcartcellsinpatientswithrelapsedrefractorylymphoma AT tongchuan crisprcas9genomeediteduniversalcartcellsinpatientswithrelapsedrefractorylymphoma AT suliping crisprcas9genomeediteduniversalcartcellsinpatientswithrelapsedrefractorylymphoma AT zhangwenying crisprcas9genomeediteduniversalcartcellsinpatientswithrelapsedrefractorylymphoma AT jiahejin crisprcas9genomeediteduniversalcartcellsinpatientswithrelapsedrefractorylymphoma AT liuyang crisprcas9genomeediteduniversalcartcellsinpatientswithrelapsedrefractorylymphoma AT yangqingming crisprcas9genomeediteduniversalcartcellsinpatientswithrelapsedrefractorylymphoma AT wuzhiqiang crisprcas9genomeediteduniversalcartcellsinpatientswithrelapsedrefractorylymphoma AT wangyao crisprcas9genomeediteduniversalcartcellsinpatientswithrelapsedrefractorylymphoma AT hanweidong crisprcas9genomeediteduniversalcartcellsinpatientswithrelapsedrefractorylymphoma |